Extended Data Fig. 5: The residual plots of sample data between the clinically used chemiluminescence immunoassay (CD) and the NELISA detection (ND).
From: Nanopore-based enzyme-linked immunosorbent assay for cancer biomarker detection
(a) CA19-9; (b) CEA; (c) AFP. The majority of the plots are evenly distributed around zero, indicating that the detection results of the two methods exhibit high consistency.
